Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (21-30 of 666) with videos related to

Pageof 67
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2017
Performance and Utility of Prognostic Genomic Biomarkers After Prostatectomy: Decipher-ing the DataDaniel E Spratt
Advances in Experimental Medicine and Biology|January 5, 2020
Prostate Cancer Transcriptomic SubtypesDaniel E Spratt
European Urology|September 5, 2024
Further Randomized Data Confirming Minimal Benefit from the Addition of Hormone Therapy to Postoperative RadiotherapyDaniel E Spratt
European Urology|March 31, 2016
Salvage Radiotherapy After Prostatectomy: Two Sides of the CoinDaniel E Spratt
The Lancet. Oncology|June 10, 2026
Preliminary results from PRIMARY2: bringing colour to a grey arenaDaniel E Spratt
Clinics in Laboratory Medicine|January 19, 1999
LC/MS with a particle beam interface in forensic toxicologyE Spratt, G M Vallaro
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Breast and Prostate Cancer: Lessons to Be SharedDaniel E Spratt, Reshma Jagsi
Oncotargets and Therapy|November 3, 2012
Current and emerging treatment options for nasopharyngeal carcinomaDaniel E Spratt, Nancy Lee
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?Himanshu Nagar, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|June 5, 2021
Dose Escalation for Oligometastatic Disease: Is More Better?Tithi Biswas, Daniel E Spratt
Pageof 67

Showing results (21-30 of 666) with videos related to

Sort By:
Pageof 67
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2017
Performance and Utility of Prognostic Genomic Biomarkers After Prostatectomy: Decipher-ing the DataDaniel E Spratt
Advances in Experimental Medicine and Biology|January 5, 2020
Prostate Cancer Transcriptomic SubtypesDaniel E Spratt
European Urology|September 5, 2024
Further Randomized Data Confirming Minimal Benefit from the Addition of Hormone Therapy to Postoperative RadiotherapyDaniel E Spratt
European Urology|March 31, 2016
Salvage Radiotherapy After Prostatectomy: Two Sides of the CoinDaniel E Spratt
The Lancet. Oncology|June 10, 2026
Preliminary results from PRIMARY2: bringing colour to a grey arenaDaniel E Spratt
Clinics in Laboratory Medicine|January 19, 1999
LC/MS with a particle beam interface in forensic toxicologyE Spratt, G M Vallaro
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Breast and Prostate Cancer: Lessons to Be SharedDaniel E Spratt, Reshma Jagsi
Oncotargets and Therapy|November 3, 2012
Current and emerging treatment options for nasopharyngeal carcinomaDaniel E Spratt, Nancy Lee
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?Himanshu Nagar, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|June 5, 2021
Dose Escalation for Oligometastatic Disease: Is More Better?Tithi Biswas, Daniel E Spratt
Pageof 67